Investigating the effect of drug therapy on laryngitis

Phase 3

Recruiting

• Conditions: Voice disorder.; Dysphonia; R49.0

• Registration Number: IRCT20221214056813N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Presence of muscle tension dysphonia
Not having a history of speech therapy
Having appropriate cognitive levels to take medicine

Exclusion Criteria

Presence of neurologic disorder
Presence of Gastric Acid Reflux

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Inflammation of the larynx. Timepoint: Measurement of laryngitis on the first day and 30 days after the start of treatment. Method of measurement: Using a laryngeal imaging device.